New drugs for multiple myeloma

Clinical Advances in Hematology and Oncology

Volumn 4, Issue 8, 2006, Pages 592-594

  Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; DEXAMETHASONE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; KOS 953; LENALIDOMIDE; MELPHALAN; NEW DRUG; PREDNISONE; THALIDOMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CYTOTOXICITY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RESEARCH; DRUG SAFETY; DRUG TARGETING; ELDERLY CARE; HUMAN; MULTIPLE MYELOMA; NEUROPATHY; NOTE; OVERALL SURVIVAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SOMNOLENCE; STEM CELL TRANSPLANTATION; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; DISEASE PROGRESSION; DRUG DESIGN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTIPLE MYELOMA; PYRAZINES; SURVIVAL RATE; THALIDOMIDE; TREATMENT OUTCOME;

EID: 33748929334     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. Facon T, Harousseau MJ, Huguet F, et al; on behalf of the Intergroupe Francophone du Myélome. Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. Proc Am Soc Clin Oncol. 2006;24(18S pt 1). Abstract 1.
2. Weber DM, Chen C, Niesvizky R, et al. Lenalidomide plus high-dose dexamethasone provides improved overall survival compared to high-dose dexamethasone alone for relapsed or refractory multiple myeloma (MM): results of a North American phase III study (MM-009). Proc Am Soc Clin Oncol. 2006;24(18S pt 1). Abstract 7521.
3. Chanan-Khan A, Richardson P, Alsina M, et al. Phase 1 clinical trial of KOS-953 + bortezomib (BZ) in relapsed refractory multiple myeloma (MM). Proc Am Soc Clin Oncol. 2006;24(18S pt 1). Abstract 3066.
4. Palumbo A, Bringhen S, Caravita T, et al; Italian Multiple Myeloma Network, GIMEMA. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomized controlled trial. Lancet. 2006;367:825-831.